Infinity Pharmaceuticals | INFI - Interest Expense On Debt

Infinity Pharmaceuticals reported $45K in Interest Expense on Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Interest Expense On Debt Change
Amgen AMGN:US USD 415M 47M
Bristol Myers Squibb BMY:US USD 294M 5M
Cytori Therapeutics CYTX:US USD 159K 14K
Gilead Sciences GILD:US USD 227M 2M
Infinity Pharmaceuticals INFI:US USD 45K 0
IONIS PHARMACEUT IONS:US USD 1.73M 408K
Novartis NOVN:VX USD 219M 4M
Pfizer PFE:US USD 313M 2M
Roche Holding ROG:VX 348M 92M
Tg Therapeutics TGTX:US USD 2.86M 1.21M
Vascular Biogenics VBLT:US USD 15K 20K
YTE INCY:US USD 667K 26K